Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials.
Christopher Ernest Maitland GriffithsMarjolein de Bruin-WellerMette DeleuranMaria-Concetta FargnoliDelphine Staumont-SalléH Chih-Ho HongJose Sánchez-CarazoPeter FoleySeong Jun SeoJérôme MsihidZhen ChenSonya L CyrAna Beatris RossiPublished in: Dermatology and therapy (2021)
ClinicalTrials.gov identifier NCT02260986, EudraCT 2013-003254-24. LIBERTY AD CAFÉ: ClinicalTrials.gov identifier NCT02755649, EudraCT 2015-002653-35.